|
1
|
Hales CA: Physiological Function of
Hypoxic Pulmonary VasoconstrictionHypoxic Pulmonary
Vasoconstriction. Springer US; pp. 3–14. 2004, View Article : Google Scholar
|
|
2
|
K L Eales, Hollinshead KE and Tennant DA:
Hypoxia and metabolic adaptation of cancer cells. Oncogenesis.
5:e1902016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vaupel P and Harrison L: Tumor hypoxia:
Causative factors, compensatory mechanisms and cellular response.
Oncologist. 9 Suppl 5:S4–S9. 2004. View Article : Google Scholar
|
|
4
|
Yamada D, Kobayashi S, Yamamoto H,
Tomimaru Y, Noda T, Uemura M, Wada H, Marubashi S, Eguchi H,
Tanemura M, et al: Role of the hypoxia-related gene, JMJD1A, in
hepatocellular carcinoma: Clinical impact on recurrence after
hepatic resection. Ann Surg Oncol. 19 Suppl 3:S3552011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andersen S, Donnem T, Al-Saad S, Al-Shibli
K, Stenvold H, Busund LT and Bremnes RM: Correlation and
coexpression of HIFs and NOTCH markers in NSCLC. Anticancer Res.
31:1603–1606. 2011.PubMed/NCBI
|
|
6
|
Coughlin SS and Ekwueme DU: Breast cancer
as a global health concern. Cancer Epidemiol. 33:315–318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chakrabarti J, Turley H, Campo L, Han C,
Harris AL, Gatter KC and Fox SB: The transcription factor DEC1
(stra13, SHARP2) is associated with the hypoxic response and high
tumour grade in human breast cancers. Br J cancer. 91:954–958.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hänze J, Eul BG, Savai R, Krick S, Goyal
P, Grimminger F, Seeger W and Rose F: RNA interference for
HIF-1alpha inhibits its downstream signalling and affects cellular
proliferation. Biochem Biophys Res Commun. 312:571–577. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Chen J, Liu F, Gao C, Wang X,
Zhao T, Liu J, Gao S, Zhao X, Ren H and Hao J: CypA, a gene
downstream of HIF-1α, promotes the development of PDAC. PLoS One.
9:e928242014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang Y, Du KM, Xue ZH, Yan H, Li D, Liu
W, Chen Z, Zhao Q, Tong JH, Zhu YS and Chen GQ: Cobalt chloride and
low oxygen tension trigger differentiation of acute myeloid
leukemic cells: possible mediation of hypoxia-inducible
factor-1alpha. Leukemia. 17:2065–2073. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Zhang J, Yang H, Wu C, Dang X and
Liu Y: Copper depletion inhibits CoCl2-induced aggressive phenotype
of MCF-7 cells via downregulation of HIF-1 and inhibition of
Snail/Twist-mediated epithelial-mesenchymal transition. Sci Rep.
5:124102015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen B, Zheng MQ, Lu JW, Jiang Q, Wang TH
and Huang XE: CXCL12-CXCR4 promotes proliferation and invasion of
pancreatic cancer cells. Asian Pac J Cancer Prev. 14:5403–5408.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo HQ, Xu M, Zhong WT, Cui ZY, Liu FM,
Zhou KY and Li XY: EGCG decreases the expression of HIF-1α and VEGF
and cell growth in MCF-7 breast cancer cells. J BUON. 19:435–439.
2014.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data usingreal-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semenza GL: The hypoxic tumor
microenvironment: A driving force for breast cancer progression.
Biochim Biophys Acta. 1863:382–391. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsutsui S, Matsuyama A, Yamamoto M,
Takeuchi H, Oshiro Y, Ishida T and Maehara Y: The Akt expression
correlates with the VEGF-A and -C expression as well as the
microvessel and lymphatic vessel density in breast cancer. Oncol
Rep. 23:621–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Z, Wu J, Liang B and Huangfu CS:
Correlationbetween hypoxia inducible factor (HIF-1α) and
epithelium-mesenchyma transform of ductal carcinoma with invasive
breast cancer. Shandong Med J. 52:90–92. 2012.
|
|
19
|
Moser C, Lang SA, Mori A, Hellerbrand C,
Schlitt HJ, Geissler EK, Fogler WE and Stoeltzing O: ENMD-1198, a
novel tubulin binding agent rdduces HIF-lalpha and STAT3 activity
in human hepatocellular carcinoma (HCC) cells and inhibits growth
and vascularization in vivo. BMC Cancer. 8:2062008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marmot MG, Altman DG, Cameron DA, Dewar
JA, Thompson SG and Wilcox M: The benefits and harms of breast
cancer screening: An independent review. Br J Cancer.
108:2205–2240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lech R and Przemyslaw O: Epidemiological
models for breast cancer risk estimation. Ginekol Pol. 82:451–454.
2011.PubMed/NCBI
|
|
23
|
Liu ZJ, Semenza GL and Zhang HF:
Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang
Univ Sci B. 16:32–43. 2015.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lundgren K, Holm C and Landberg G: Hypoxia
and breast cancer: Prognostic and therapeutic implications. Cell
Mol Life Sci. 64:3233–3247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SJ, Kim JG, Kim ND, Yang K, Shim JW
and Heo K: Estradiol, TGF-β1 and hypoxia promote breast cancer
stemness and EMT-mediated breast cancer migration. Oncol Lett.
11:1895–1902. 2016.PubMed/NCBI
|
|
26
|
Bradbury J: Breathing hard to keep up with
HIF-1. Lancet. 358:17042001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cancer Genome Atlas Network, .
Comprehensive molecular portraits of human breast tumours. Nature.
490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Generali D, Berruti A, Brizzi MP, Campo L,
Bonardi S, Wigfield S, Bersiga A, Allevi G, Milani M, Aguggini S,
et al: Hypoxiainducible factor-1alpha expression predicts a poor
response to primary chemoendocrine therapy and disease-free
survival in primary human breast cancer. Clin Cancer Res.
12:4562–4568. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gruber G, Greiner RH, Hlushchuk R,
Aebersold DM, Altermatt HJ, Berclaz G and Djonov V:
Hypoxia-inducible factor 1alpha in high-risk breast cancer: An
independent prognostic parameter. Breast Cancer Res. 6:R191–R198.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goswami S, Sahai E, Wyckoff JB, Cammer M,
Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS:
Macrophages promote the invasion of breast carcinoma cells via a
colony-stimulating factor-1/epidermal growth factor paracrine loop.
Cancer Res. 65:5278–5283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rahimi M, Toth TA and Tang CK: CXCR4
suppression attenuates EGFRVIII mediated invasion and induces p38
MAPK-dependent protein trafficking and degradation of EGFRvIII in
breast cancer cells. Cancer Lett. 306:43–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Helbig G, Christopherson KW II,
Bhat-Nakshatfi P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Parker CC, Kim RH, Li BD and Chu QD: The
chemokine receptor CXCR4 as a novel independent prognosic marker
for node-positive breast cancer patients. J Surg Oncol.
106:393–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dunn LK, Mohammad KS, Fournier PG, McKenna
CR, Davis HW, Niewolna M, Peng XH, Chirgwin JM and Guise TA:
Hypoxia and TGF-beta drive breast cancer bone metastases through
parallel signaling pathways in tumor cells and the bone
microenvironment. PLoS One. 4:e68962009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Citti A, Boldrini R, Inserra A, Alisi A,
Pessolano R, Mastronuzzi A, Zin A, De Sio L, Rosolen A, Locatelli F
and Fruci D: Expression of multidrug resistance-associated proteins
in paediatric soft tissue sarcomas before and after chemotherapy.
Int J Oncol. 41:117–124. 2012.PubMed/NCBI
|
|
36
|
Mego M, Cholujova D, Minarik G, Sedlackova
T, Gronesova P, Karaba M, Benca J, Cingelova S, Cierna Z, Manasova
D, et al: CXCR4-SDF-1 interaction potentially mediates trafficking
of circulating tumor cells in primary breast cancer. Bmc Cancer.
16:1272016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Timoshenko AV, Chakraborty C, Wagner GF
and Lala PK: COX-2-mediated stimulation of the lymphangiogenic
factor VEGF-C in human breast cancer. Br J Cancer. 94:1154–1163.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Komatsu DE and Hadjiargyrou M: Activation
of the transcription factor HIF-1 and its target genes, VEGF, HO-1,
iNOS, during fracture repair. Bone. 34:680–688. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Semenza GL: Expression of
hypoxia-inducible factor 1: Mechanisms and consequences. Biochem
Pharmacol. 59:47–53. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li G, He L, Zhang E, Shi J, Zhang Q, Le
AD, Zhou K and Tang X: Overexpression of human papillomavirus (HPV)
type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and
VEGF expression in non-small cell lung cancer cells. Cancer Lett.
311:160–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dong X, Wang YS, Dou GR, Hou HY, Shi YY,
Zhang R, Ma K, Wu L, Yao LB, Cai Y and Zhang J: Influence of Dll4
via HIF-1α-VEGF signaling on the angiogenesis of choroidal
neovascularization under hypoxic conditions. PLoS One.
6:e184812011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ward C, Langdon SP, Mullen P, Harris AL,
Harrison DJ, Supuran CT and Kunkler IH: New strategies for
targeting the hypoxic tumour microenvironment in breast cancer.
Cancer Treat Rev. 39:171–179. 2013.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lopez-Haber C, Barrio-Real L,
Casado-Medrano V and Kazanietz MG: Heregulin/ErbB3 signaling
enhances CXCR4-driven rac1 activation and breast cancer cell
motility via hypoxia-inducible factor 1α. Mol Cell Biol.
36:2011–2026. 2016. View Article : Google Scholar : PubMed/NCBI
|
